Copyright
©The Author(s) 2023.
World J Diabetes. Nov 15, 2023; 14(11): 1659-1671
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1659
Published online Nov 15, 2023. doi: 10.4239/wjd.v14.i11.1659
Table 3 Key targets and component docking results
| ID | Compounds | Minimum binding energy (kcal/mol) | ||||
| TNF | IL-6 | TP53 | EGFR | INS | ||
| MOL000098 | Quercetin | -7.61 | -6.88 | -7.43 | -6.14 | -7.72 |
| MOL000392 | Formononetin | -6.56 | -6.75 | -6.12 | -7.11 | -6.21 |
| MOL000422 | Kaempferol | -6.7 | -6.78 | -6.19 | -6.21 | -14.8 |
| MOL000378 | 7-O-methylisomucronulatol | -6.95 | -6.68 | -6.42 | -5.98 | -5.75 |
| MOL000354 | Isorhamnetin | -4.62 | -4.56 | -4.48 | -4.27 | -4.46 |
- Citation: Wang YJ, Wang YL, Jiang XF, Li JE. Molecular targets and mechanisms of Jiawei Jiaotai Pill on diabetic cardiomyopathy based on network pharmacology. World J Diabetes 2023; 14(11): 1659-1671
- URL: https://www.wjgnet.com/1948-9358/full/v14/i11/1659.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i11.1659